Relay Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:RLAY) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 75.08 M57.87 M73.21 M55.26 M62.12 M44.87 M 235.46 M Cash from investing activities 14 M-29 M42.47 M75.15 M39.73 M35.46 M 192.8 M Cash from financing activities 218.89 M800 K48.92 M1.54 M218.89 M800 K — Free cash flow 74.86 M57.87 M72.83 M55.23 M62.12 M44.86 M 235.04 M

Notizie

Relay Therapeutics stock hits 52-week high at 9.64 USD

Gli EPS di Relay hanno battuto le aspettative per 0,09$, il fatturato supera le previsioni

Relay earnings beat by $0.09, revenue topped estimates

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Utili Relay Therapeutics sotto i riflettori dopo svolta FDA

Relay Therapeutics earnings in spotlight after FDA breakthrough

BB Biotech FY 2025: utili +660%, outlook 2026 cauto

Relay earnings in focus as FDA breakthrough fuels optimism

Le azioni di Relay Therapeutics salgono dopo lo status di Breakthrough Therapy della FDA

Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status

FDA concede lo status di terapia innovativa al farmaco di Relay per il cancro al seno

FDA grants breakthrough therapy status to Relay’s breast cancer drug